News & Analysis on Biopharmaceutical Manufacturing & Bioprocessing Tech
Akrevia: Joseph Farmer
By Ben Hargreaves & Maggie Lynch
- Last updated on
Joseph Farmer will take on the role as COO at the privately held biopharma company Akrevia Therapeutics. The company, which was launched by Atlas Ventures and F-Prime in September 2018, will see Farmer take on business development functions as it works on its development candidates.
Farmer, who previously served as SVP and general counsel at Tesaro, will lead finance, administrative, and business operations at the company, directly reporting to René Russo who was appointed CEO just last month.
Russo commented on the appointment of Farmer stating, “As we focus on the next phase of Akrevia’s growth, I am thrilled to welcome Jo as our COO.”
She continued, “This is an exciting time for the company as we approach nomination of our first development candidates from our tumor-activated IL-2 and anti-CTLA4 programs, unlock the full potential of our Aklusion platform technology and work to deliver on our long-term strategy to build a leading immuno-oncology company.”